Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 2352139, 9 pages
https://doi.org/10.1155/2018/2352139
Research Article

High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma

1Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
2Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
3Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4State Key Laboratory & Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

Correspondence should be addressed to Shusen Zheng and Weilin Wang

Received 19 August 2017; Revised 10 December 2017; Accepted 24 December 2017; Published 4 February 2018

Academic Editor: Shinichi Aishima

Copyright © 2018 Yu Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Rizvi and G. J. Gores, “Pathogenesis, diagnosis, and management of cholangiocarcinoma,” Gastroenterology, vol. 145, no. 6, pp. 1215–1229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Njei, “Changing pattern of epidemiology in intrahepatic cholangiocarcinoma,” Hepatology, vol. 60, no. 3, pp. 1107-1108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Patel, “Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States,” Hepatology, vol. 33, no. 6, pp. 1353–1357, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Sia, V. Tovar, A. Moeini, and J. M. Llovet, “Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies,” Oncogene, vol. 32, no. 41, pp. 4861–4870, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Ben-Menachem, “Risk factors for cholangiocarcinoma,” European Journal of Gastroenterology & Hepatology, vol. 19, no. 8, pp. 615–617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Farges and D. Fuks, “Clinical presentation and management of intrahepatic cholangiocarcinoma,” Gastroentérologie Clinique et Biologique, vol. 34, no. 3, pp. 191–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Cardinale, R. Semeraro, and A. Torrice, “Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors,” World Journal of Gastrointestinal Oncology, vol. 2, no. 11, pp. 407–416, 2010. View at Publisher · View at Google Scholar
  8. A. Moeini, D. Sia, N. Bardeesy, V. Mazzaferro, and J. M. Llovet, “Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma,” Clinical Cancer Research, vol. 22, no. 2, pp. 291–300, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Potkonjak, J. T. Miura, K. K. Turaga et al., “Intrahepatic cholangiocarcinoma and gallbladder cancer: Distinguishing molecular profiles to guide potential therapy,” HPB, vol. 17, no. 12, pp. 1119–1123, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Guglielmi, A. Ruzzenente, T. Campagnaro et al., “Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection,” World Journal of Surgery, vol. 33, no. 6, pp. 1247–1254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Patel, “New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma,” Journal of Gastroenterology, vol. 49, no. 2, pp. 165–172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. D. Jones, A. Van Der Flier, and A. Sonnenberg, “Genomic organization of the human α3 integrin subunit gene,” Biochemical and Biophysical Research Communications, vol. 248, no. 3, pp. 896–898, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Dedhar, V. Gray, K. Robertson, and R. Saulnier, “Identification and characterization of a novel high-molecular-weight form of the integrin α3 subunit,” Experimental Cell Research, vol. 203, no. 1, pp. 270–275, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. M. V. Denadai, L. S. Viana, R. J. Affonso Jr. et al., “Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma,” BMC Clinical Pathology, vol. 13, no. 1, article 16, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kurozumi, Y. Goto, R. Matsushita et al., “Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer,” Cancer Science, vol. 107, no. 1, pp. 84–94, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Pochec, A. Lityńska, A. Amoresano, and A. Casbarra, “Glycosylation profile of integrin α3β1 changes with melanoma progression,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1643, no. 1-3, pp. 113–123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. Coopman, D. M. Thomas, K. R. Gehlsen, and S. C. Mueller, “Integrin participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells,” Molecular Biology of the Cell (MBoC), vol. 7, no. 11, pp. 1789–1804, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Patriarca, D. Ivanyi, D. Fles et al., “Distribution of extracellular and cytoplasmic domains of the α3 and α6 integrin subunits in solid tumors,” International Journal of Cancer, vol. 63, no. 2, pp. 182–189, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Wang, Q. Xie, X. Zhou et al., “Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells,” Cancer Letters, vol. 358, no. 1, pp. 47–58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Zhou, L. Zhang, B. Zheng et al., “MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin-2,” Cancer Science, vol. 107, no. 4, pp. 424–432, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. A. K. Chakraborty, Y. Funasaka, M. Ichihashi, and J. M. Pawelek, “Upregulation of alpha and beta integrin subunits in metastatic macrophage-melanoma fusion hybrids,” Melanoma Research, vol. 19, no. 6, pp. 343–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Li and W. Li, “Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation,” Pharmacology & Therapeutics, vol. 150, pp. 33–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. X.-X. Jie, X.-Y. Zhang, and C.-J. Xu, “Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications,” Oncotarget , vol. 8, no. 46, pp. 81558–81571, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. P. G. Santamaria, G. Moreno-Bueno, F. Portillo, and A. Cano, “EMT: Present and future in clinical oncology,” Molecular Oncology, vol. 11, no. 7, pp. 718–738, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. T. C. M. Klinowska, C. M. Alexander, E. Georges-Labouesse et al., “Epithelial development and differentiation in the mammary gland is not dependent on α3 or α6 integrin subunits,” Developmental Biology, vol. 233, no. 2, pp. 449–467, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Xin-Wei, L. Liang, H. Guo-Jun et al., “STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome,” Oncotarget , vol. 8, no. 5, pp. 7710–7721, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Ruzzenente, S. Conci, A. Valdegamberi, C. Pedrazzani, and A. Guglielmi, “Role of surgery in the treatment of intrahepatic cholangiocarcinoma,” European Review for Medical and Pharmacological Sciences, vol. 19, no. 15, pp. 2892–2900, 2015. View at Google Scholar · View at Scopus